TY  - JOUR
AU  - Adams JM
AU  - Cory S
TI  - The Bcl-2 protein family: Arbiters of cell survival
JA  - Science
PY  - 1998///
VL  - 281
SP  - 1322
EP  - 1326
PB  - Cancer Research Campaign
M3  - 10.1126/science.281.5381.1322
N1  - 10.1126/science.281.5381.1322
UR  - http://dx.doi.org/10.1126/science.281.5381.1322
ER  - 

TY  - JOUR
AU  - Allen RT
AU  - Cluck MW
AU  - Agrawal DK
TI  - Mechanisms controlling cellular suicide: role of Bcl-2 and caspases
JA  - Cell Mol Life Sci
PY  - 1998///
VL  - 54
SP  - 427
EP  - 445
PB  - Cancer Research Campaign
M3  - 10.1007/s000180050171
N1  - 10.1007/s000180050171
UR  - http://dx.doi.org/10.1007/s000180050171
ER  - 

TY  - JOUR
AU  - Berchem GJ
AU  - Bosseler M
AU  - Sugars LY
AU  - Voeller HJ
AU  - Zeitlin S
AU  - Gellmann EP
TI  - Androgens induce resistance to Bcl-2-mediated apoptosis in LNCaP prostate cancer cells
JA  - Cancer Res
PY  - 1995///
VL  - 55
SP  - 735
EP  - 738
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Chittenden T
AU  - Flemmington C
AU  - Houghton AB
AU  - Ebb RG
AU  - Gallo GL
AU  - Elangovan B
AU  - Chinnadurai G
AU  - Lutz RJ
TI  - A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding function
JA  - EMBO J
PY  - 1995///
VL  - 14
SP  - 5589
EP  - 5596
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Colombel M
AU  - Symmans F
AU  - Gil S
AU  - O/'Toole KM
AU  - Chopin D
AU  - Benson M
AU  - Olsson CA
AU  - Korsmeyer S
AU  - Buttyan R
TI  - Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers
JA  - Am J Pathol
PY  - 1993///
VL  - 143
SP  - 390
EP  - 400
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Diaz JL
AU  - Oltersdorf T
AU  - Horne W
AU  - McConnell M
AU  - Wilson G
AU  - Weeks S
AU  - Garcia T
AU  - Fritz CF
TI  - A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members
JA  - J Biol Chem
PY  - 1997///
VL  - 272
SP  - 11350
EP  - 11355
PB  - Cancer Research Campaign
M3  - 10.1074/jbc.272.17.11350
N1  - 10.1074/jbc.272.17.11350
UR  - http://dx.doi.org/10.1074/jbc.272.17.11350
ER  - 

TY  - JOUR
AU  - Haldar S
AU  - Chintapalli J
AU  - Croce CM
TI  - Taxol induces Bcl-2 phosphorylation and death in prostate cancer cells
JA  - Cancer Res
PY  - 1996///
VL  - 56
SP  - 1253
EP  - 1255
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Han JP
AU  - Sabbatini P
AU  - Perez D
AU  - Rao L
AU  - Modha D
AU  - White E
TI  - The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein
JA  - Genes Dev
PY  - 1996///
VL  - 10
SP  - 461
EP  - 477
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Hirotani M
AU  - Zhang Y
AU  - Fujita N
AU  - Naito M
AU  - Tsuruo T
TI  - NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis
JA  - J Biol Chem
PY  - 1999///
VL  - 274
SP  - 20415
EP  - 20420
PB  - Cancer Research Campaign
M3  - 10.1074/jbc.274.29.20415
N1  - 10.1074/jbc.274.29.20415
UR  - http://dx.doi.org/10.1074/jbc.274.29.20415
ER  - 

TY  - JOUR
AU  - Jurgensmeier JM
AU  - Xie Z
AU  - Deveraux Q
AU  - Ellerby L
AU  - Bredesen D
AU  - Reed JC
TI  - Bax directly induces release of cytochrome c from isolated mitochondria
JA  - Proc Natl Acad Sci USA
PY  - 1998///
VL  - 95
SP  - 4997
EP  - 5002
PB  - Cancer Research Campaign
M3  - 10.1073/pnas.95.9.4997
N1  - 10.1073/pnas.95.9.4997
UR  - http://dx.doi.org/10.1073/pnas.95.9.4997
ER  - 

TY  - JOUR
AU  - Krajewska M
AU  - Krajewski S
AU  - Epstein JI
AU  - Shabaik A
AU  - Sauvageot J
AU  - Song K
AU  - Kitada S
AU  - Reed JC
TI  - Immunohistochemical analysis of bcl-2, bax, bcl-xL, and mcl-1 expression on prostate cancers
JA  - Am J Pathol
PY  - 1996///
VL  - 148
SP  - 1567
EP  - 1576
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Kreis W
TI  - Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer
JA  - Cancer Invest
PY  - 1995///
VL  - 13
SP  - 296
EP  - 312
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Kroemer G
TI  - The proto-oncogene Bcl-2 and its role in regulating apoptosis
JA  - Nature Med
PY  - 1997///
VL  - 3
SP  - 614
EP  - 620
PB  - Cancer Research Campaign
M3  - 10.1038/nm0697-614
N1  - 10.1038/nm0697-614
UR  - http://dx.doi.org/10.1038/nm0697-614
ER  - 

TY  - JOUR
AU  - Mackey TJ
AU  - Borkowski A
AU  - Amin P
AU  - Jacobs SC
AU  - Kyprianou N
TI  - bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer
JA  - Urology
PY  - 1998///
VL  - 52
SP  - 1085
EP  - 1090
PB  - Cancer Research Campaign
M3  - 10.1016/S0090-4295(98)00360-4
N1  - 10.1016/S0090-4295(98)00360-4
UR  - http://dx.doi.org/10.1016/S0090-4295(98)00360-4
ER  - 

TY  - JOUR
AU  - McDonnell TJ
AU  - Troncoso P
AU  - Brisbay SM
AU  - Logothetis C
AU  - Chung LW
AU  - Hsieh JT
AU  - Tu SM
AU  - Campbell ML
TI  - Expression of the proto-oncogene Bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
JA  - Cancer Res
PY  - 1992///
VL  - 52
SP  - 6940
EP  - 6944
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Mundle SD
AU  - Gregory SA
AU  - Preislert HD
AU  - Raza A
TI  - Enzymatic programming of apoptotic cell death
JA  - Pathiobiol
PY  - 1996///
VL  - 64
SP  - 161
EP  - 170
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Oltvai ZN
AU  - Milliman CL
AU  - Korsmeyer SJ
TI  - Bcl-2 heterodimerizes in-vivo with a conserved homolog, Bax, that accelerates programmed cell death
JA  - Cell
PY  - 1993///
VL  - 74
SP  - 609
EP  - 619
PB  - Cancer Research Campaign
M3  - 10.1016/0092-8674(93)90509-O
N1  - 10.1016/0092-8674(93)90509-O
UR  - http://dx.doi.org/10.1016/0092-8674(93)90509-O
ER  - 

TY  - JOUR
AU  - Orth K
AU  - Dixit VM
TI  - Bik and Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis
JA  - J Biol Chem
PY  - 1997///
VL  - 272
SP  - 8841
EP  - 8844
PB  - Cancer Research Campaign
M3  - 10.1074/jbc.272.14.8841
N1  - 10.1074/jbc.272.14.8841
UR  - http://dx.doi.org/10.1074/jbc.272.14.8841
ER  - 

TY  - JOUR
AU  - Otter I
AU  - Conus S
AU  - Ravn U
AU  - Rager M
AU  - Olivier R
AU  - Monney L
AU  - Fabbro D
AU  - Borner C
TI  - The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli
JA  - J Biol Chem
PY  - 1998///
VL  - 273
SP  - 6110
EP  - 6120
PB  - Cancer Research Campaign
M3  - 10.1074/jbc.273.11.6110
N1  - 10.1074/jbc.273.11.6110
UR  - http://dx.doi.org/10.1074/jbc.273.11.6110
ER  - 

TY  - JOUR
AU  - Pan G
AU  - O/'Rourke K
AU  - Dixit VM
TI  - Caspase-9, Bcl-XL, and Apaf-1 form a terniary complex
JA  - J Biol Chem
PY  - 1998///
VL  - 273
SP  - 5841
EP  - 5845
PB  - Cancer Research Campaign
M3  - 10.1074/jbc.273.10.5841
N1  - 10.1074/jbc.273.10.5841
UR  - http://dx.doi.org/10.1074/jbc.273.10.5841
ER  - 

TY  - JOUR
AU  - Rokhlin OW
AU  - Bishop GA
AU  - Hostager BS
AU  - Waldschmidt TJ
AU  - Sidorenko SP
AU  - Pavloff N
AU  - Kiefer MC
AU  - Umansky SR
AU  - Glover RA
AU  - Cohen MB
TI  - Fas-mediated apoptosis in human prostatic carcinoma cell lines
JA  - Cancer Res
PY  - 1997///
VL  - 57
SP  - 1758
EP  - 1768
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Tang DG
AU  - Porter AT
TI  - Target to apoptosis: a hopeful weapon for prostate cancer
JA  - Prostate
PY  - 1997///
VL  - 32
SP  - 284
EP  - 293
PB  - Cancer Research Campaign
M3  - 10.1002/(SICI)1097-0045(19970901)32:4<284::AID-PROS9>3.3.CO;2-3
N1  - 10.1002/(SICI)1097-0045(19970901)32:4<284::AID-PROS9>3.3.CO;2-3
UR  - http://dx.doi.org/10.1002/(SICI)1097-0045(19970901)32:4<284::AID-PROS9>3.3.CO;2-3
ER  - 

TY  - JOUR
AU  - Yang E
AU  - Korsmeyer SJ
TI  - Molecular thanatopsis: a discourse on the Bcl-2 family and cell death
JA  - Blood
PY  - 1996///
VL  - 88
SP  - 386
EP  - 401
PB  - Cancer Research Campaign
ER  - 

TY  - JOUR
AU  - Yang E
AU  - Zha J
AU  - Jockel J
AU  - Boise LH
AU  - Thompson CB
AU  - Korsmeyer SJ
TI  - Bad, a heterodimeric partner for Bcl-xLand Bcl-2, displaces Bax and promotes cell death
JA  - Cell
PY  - 1995///
VL  - 80
SP  - 285
EP  - 291
PB  - Cancer Research Campaign
M3  - 10.1016/0092-8674(95)90411-5
N1  - 10.1016/0092-8674(95)90411-5
UR  - http://dx.doi.org/10.1016/0092-8674(95)90411-5
ER  - 

TY  - JOUR
AU  - Yin XM
AU  - Oltvai ZN
AU  - Korsmeyer SJ
TI  - BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
JA  - Nature
PY  - 1994///
VL  - 369
SP  - 321
EP  - 323
PB  - Cancer Research Campaign
M3  - 10.1038/369321a0
N1  - 10.1038/369321a0
UR  - http://dx.doi.org/10.1038/369321a0
ER  - 

TY  - JOUR
AU  - Zha H
AU  - Aime-Sempe C
AU  - Sato T
AU  - Reed JC
TI  - Proapoptotic protein Bax heterodimerises with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2
JA  - J Biol Chem
PY  - 1996///
VL  - 271
SP  - 7440
EP  - 7444
PB  - Cancer Research Campaign
M3  - 10.1074/JBC.271.23.13392
N1  - 10.1074/JBC.271.23.13392
UR  - http://dx.doi.org/10.1074/JBC.271.23.13392
ER  - 

TY  - JOUR
AU  - Zhou XM
AU  - Liu Y
AU  - Payne G
AU  - Lutz RJ
AU  - Chittenden T
TI  - Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155
JA  - J Biol Chem
PY  - 2000///
VL  - 275
SP  - 25046
EP  - 25051
PB  - Cancer Research Campaign
M3  - 10.1074/jbc.M002526200
N1  - 10.1074/jbc.M002526200
UR  - http://dx.doi.org/10.1074/jbc.M002526200
ER  - 

TY  - JOUR
AU  - Zhu W
AU  - Cowie A
AU  - Wasfy GW
AU  - Penn LZ
AU  - Leber B
AU  - Andrews DW
TI  - Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types
JA  - EMBO J
PY  - 1996///
VL  - 15
SP  - 4130
EP  - 4141
PB  - Cancer Research Campaign
ER  - 

